PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

NCT03226249 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma
Lymphocyte-Depleted Classical Hodgkin Lymphoma
Lymphocyte-Rich Classical Hodgkin Lymphoma
Mixed Cellularity Classical Hodgkin Lymphoma
Nodular Sclerosis Classical Hodgkin Lymphoma

Interventions

PROCEDURE: Computed Tomography
DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
RADIATION: Fludeoxyglucose F-18
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Vinblastine Sulfate

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]